Patients Stopping Slimming Medications Gain Back Pounds Four Times Faster Than Those on Conventional Diets

A recent study suggests that individuals who stop using popular slimming jabs like semaglutide or tirzepatide tend to recover shed pounds much more quickly than those who stop traditional diet and exercise programs.

Research printed in a prominent medical journal demonstrates that while obese individuals often shed a large proportion of their total mass while using the jabs, the mass comes back at an estimated rate of nearly a kilo each month once they quit.

"Users purchasing these drugs must be cognizant of the danger of rapid weight regain when the therapy concludes," stated expert Dr. Susan Jebb.

This pace of recovery implies a reversion to original mass within about 18 months.

Comparing Treatments

The analysis, which examined 37 of trials involving over 9,000 of participants, compared the results of these new drugs with other pills.

The team emphasize that people who lose weight through lifestyle changes alone generally have a more gradual creep back—perhaps 100 grams monthly—once they finish.

The Reason for the Rapid Regain

Experts propose the mode of action of the drugs accounts for the heightened weight return.

The injections copy a natural hormone called GLP-1, which controls appetite.

"Artificially providing GLP-1 concentrations far above than normal might result in the system to generate a reduced amount of its own natural hormone, and could diminish sensitivity to its actions," said Dr. Adam Collins, a nutrition expert.

"Stopping of this medication means hunger is unsuppressed, making overeating much more probable."

A Lifelong Condition?

Medical guidelines advise the jabs for people with weight-linked health risks, alongside recommended lifestyle changes.

Many experts argue that, given the high risk of relapse, the therapy should be considered long-term.

This view is reinforced by pharmaceutical companies, who say that the findings "emphasize the persistent nature of obesity," akin to managing conditions like high blood pressure.

User Accounts

People who have stopped the medication report a sudden resurgence of appetite.

"It was like a trigger flipping and you become ravenous," recalled an individual.

The struggle is worsened if users have not developed lasting lifestyle or habit changes during treatment.

Significant Use

Recent estimates indicate that a significant number of people in the UK have tried these injections in the last 12 months, with interest remaining high.

• Adoption is more common among females compared to males.
• The 40s and 50s demographic shows the greatest usage rates.
• Many obtain the drugs through private healthcare rather than public health services.

Finally, researchers emphasize that while GLP-1 drugs are effective tools for shedding pounds, they are not a permanent solution and long-term success likely depends on combined behavioural changes.